Orlando, FL – OutcomeRx announces the appointment of Kirby Eng, R.Ph to the position of Chief Clinical Officer. As a key member of the executive team, Kirby will be responsible for the clinical solutions that complement OutcomeRx’s industry leading reinsurance solution for cell and gene-based therapies.
Kirby has over 30 years of proven healthcare leadership in developing clinical, operational, and financial solutions across a broad base of stakeholders that include payors, manufacturers, specialty pharmacies, providers, patients, specialty distributors and group purchasing organizations. “I am honored and look forward to being part of the OutcomeRx team as we are uniquely positioned to provide the financial and risk protection for revolutionary therapies as well as achieving better overall patient outcomes.”
Kirby has been published in leading health care publications as a subject matter expert providing thought leadership and standards of care across the most complex medical conditions. According to Kirby, “It is abundantly clear that life altering cell and gene-based therapies will require novel payment models and unprecedented stakeholder alignment to maximize their clinical and economic benefits, which OutcomeRx can facilitate. I am excited to work with our customers and industry partners to provide covered members with personalized treatment and care management at credentialed Centers of Excellence.”
According to Joe Morse, OutcomeRx CEO, “Kirby brings unique breadth and depth of health care leadership experiences, and we look forward to collaboratively aligning our reinsurance and warranty products with the clinical and financial interests of payors, manufacturers, providers, and patients. Kirby’s dedication to patient-centric solutions is steadfast and we are fortunate to have him join the company to help accelerate access to the personalized care that patients deserve.”